The AMR Diagnostic (Dx) Use Accelerator is a platform to evaluate a package of interventions and provide evidence to inform policy change that can positively impact antimicrobial resistance (AMR) and contribute to universal health coverage (UHC).The AMR Dx Use Accelerator will ultimately help prepare for the introduction of new diagnostics and provide a safe environment for new antibiotics to enjoy a longer useful therapeutic lifespan.

In the first instance interventions focus on improving management of patients presenting with fever, by providing and evaluating a “toolbox” that can help healthcare professionals provide more targeted treatments. By adopting available diagnostic tests and other diagnosis aids, and encouraging behaviour changes in outpatient clinics, we hope to rationalize the use of antibiotics.

To generate the data to support this toolbox, we are conducting studies at 4 sites in India. The studies in India are being conducted through a partnership with the Indian Council of Medical Research (ICMR).

• The project aims to create evidence for policy on use of diagnostics to reduce the incidence of AMR.
• The studies planned under the project will also provide data to inform the World Health Organization and in-country policy makers, with the aim of informing new patient care algorithms.